We hypothesize that point mutations in the bHLH domain of TCF4, known for PTHS patients, influence pattern of distribution in nucleus and function of TCF4 probably by changes in DNA binding specificity. This evidence concerns the gene TCF4 and Pitt-Hopkins syndrome.